RISA Labs, a Palo Alto, CA-based AI-powered workflow automation company in oncology, has raised $3.5 million in seed funding.
Investors
The round was led by Binny Bansal, co-founder of Flipkart, with additional participation from Oncology Ventures, General Catalyst, z21 Ventures, ODD BIRD VC, and Ashish Gupta.
RISA Labs Use of Funds
The company will use the funding to deploy its platform across 100 cancer centers over the next two years, improving cancer care efficiency and reducing delays.
About RISA Labs
Founded by Kshitij Jaggi and Kumar Shivang, RISA Labs is an oncology AI company focused on transforming healthcare operations with its innovative platform. Its flagship platform, BOSS (Business Operating System as a Service), utilizes advanced AI technologies—including large language models (LLMs), digital twins, and reinforcement learning—to streamline complex healthcare workflows. BOSS automates the prior authorization process in oncology, a critical area where delays can significantly impact patient outcomes. RISA Labs' long-term vision is to build a unified layer for AI-driven orchestration in oncology.
Funding Details
Company: RISA Labs, Inc.
Raised: $3.5M
Round: Seed
Funding Date: April 2025
Lead Investor: Binny Bansal
Additional Investors: Oncology Ventures, General Catalyst, z21 Ventures, ODD BIRD VC, Ashish Gupta
Company Website: https://www.risalabs.com/
Software Category: Healthcare AI & Workflow Automation
Source: https://www.globenewswire.com/news-release/2025/04/17/3063501/0/en/RISA-Labs-Raises-3-5M-to-Eliminate-Treatment-Delays-with-AI-Powered-Workflow-Automation-in-Oncology.html